Alimera

It’s our shared vision that propels us forward. 💪🌟 From long-lasting retinal treatments to positive outcomes in collaboration with providers, we believe in the strength of collective efforts. One of us is never as valuable as ALL of us. Learn how We See More, Together™ here: https://bit.ly/3Tgrunl

Are you passionate about ophthalmology and looking for a new and exciting opportunity? We're expanding our team in Germany and we want you to be a part of our innovative and dynamic organization. Check out some of the exciting positions we are hiring for: 🌟 MSL - North East Germany 🌟 Clinical Account Specialist - Frankfurt, Aschaffenburg, Wuerzburg 🌟Clinical Account Specialist - Augsburg, Ingolstadt, Nuremberg For more details & to apply click here! 👇 https://lnkd.in/eGzNQFke

At the heart of our company is a shared passion for protecting the retina and preserving vision. Through our collective knowledge, durable treatments, and collaborative efforts with providers, patients, and partners, we are committed to making a positive difference. Learn more about our journey to protect and enhance vision on our website here: https://bit.ly/3Tgrunl

Stay up-to-date on some exciting things happening at Alimera. Click to read more: https://bit.ly/3Rw4Plj

We are proud of the impact we are making in the world of vision. Check out our news: https://bit.ly/4b7mZ3S

Join us in celebrating these June work anniversaries for another amazing year of helping patients see clearly! 🎊 Each year brings new accomplishments, new challenges, and new successes, so thank you for all you do as part of our Alimera team. 👏 https://bit.ly/3Tgrunl

Alimera is excited to engage with other retinal thought leaders at Clinical Trials at the Summit (CTS) in Park City, Utah. Come see us as we contribute to the discourse on ongoing clinical trials and the latest data driving progress in retinal health. https://bit.ly/3Tgrunl

Completion of enrollment in the SYNCHRONICITY Study for YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is a key step in assessing its impact. This article from the @ReviewofOphthalmology delves into the study's progress and sheds light on the potential impact YUTIQ has on advancing ophthalmological treatment. Read the full article here: https://bit.ly/3P01idK

May is full of opportunities to connect! 🌟 Mark your calendars as we gear up for these exciting events across the country, sharing our advancements and contributions to #retinahealth. https://bit.ly/3Tgrunl

Our vision is to be the place to be in retina, providing available vision-improving treatments for retinal diseases like diabetic macular edema and chronic noninfectious uveitis affecting the back of the eye. ✨👁️ Learn more about Alimera and our mission here: https://bit.ly/3Tgrunl